Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000047
Filing Date
2025-02-03
Accepted
2025-02-03 16:29:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2856
  Complete submission text file 0001964306-25-000047.txt   4287
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVE. SANTA MONICA CA 90404
Business Address
MOORE TIMOTHY L. (Reporting) CIK: 0001669207 (see all company filings)

Type: 144

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38693 | Film No.: 25582953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)